Christoph Engeler is a partner in the Hamburg office. Mr. Engeler practices in the firm’s Corporate Department, focusing on corporate and regulatory matters in the healthcare and life sciences industries.
He has a wealth of experience advising domestic and international hospital and nursing home operators as well as financial investors in healthcare institutions on M&A transactions and restructurings. He further advises public authorities on privatizations of healthcare institutions and joint ventures.
In the life sciences sector, Mr. Engeler advises German and foreign pharmaceuticals companies and manufacturers of medical devices on M&A transactions as well as German and EU regulatory matters, including clinical trials, manufacturing, marketing authorizations, distribution, promotion and marketing, interaction with healthcare professionals, vigilance, and reimbursement.
Mr. Engeler is regularly recommended by leading publications (JUVE, Chambers, The Legal 500, Handelsblatt Best Lawyers). Christoph Engeler is "very quick at grasping industry-specific concepts covered in negotiations, understanding what the client is trying to achieve and conveying it to the counterparty." (Chambers Europe Germany 2017). “Life Science Star for Germany in particular for Financial & Transactional” (LMG Life Sciences 2015).